Fylde and Wyre Policies

Fylde and Wyre Policies
Click each header to expand its content

Commissioning Policies

NameSizeHits
Fwccg-Commissioning-Policies-Introductory-Document 89 KB6
Fwccg-Commissioning-Policy-No-10-Treatment-of-Varicose-Veins 0.1 MB14
Fwccg-Commissioning-Policy-No-12-Testing-for-Malignant-Hyperthermia 0.1 MB4
Fwccg-Commissioning-Policy-No-17-Services-that-are-the-subject-of-Guidance-from-the-National-Institute-of-Health-and-Clinical-Excellence 0.1 MB4
Fwccg-Commissioning-Policy-No-19-Specified-Services-for-which-provision-in-service-agreements-may-be-limited 0.2 MB8
Fwccg-Commissioning-Policy-No-2-Choice-of-Service-Provider-for-Health-Care-Ver2 0.2 MB3
Fwccg-Commissioning-Policy-No-20-Specified-Expensive-Services 0.1 MB3
Fwccg-Commissioning-Policy-No-21-Specified-Non-clinical-issues 0.1 MB3
Fwccg-Commissioning-Policy-No-24-Complex-Cases-through-the-Commissioning-Panel 0.2 MB4
Fwccg-Commissioning-Policy-No-26-Lumbar-spine-procedures 0.3 MB3
Fwccg-Commissioning-Policy-No-3-Monitoring-Enforcing-of-CCG-Policies-for-the-Comm-of-Appropriate-Effective-and-Priority-Health-Care 0.1 MB3
Fwccg-Commissioning-Policy-No-34-Spinal-Cord-Stimulation 38 KB5
Fwccg-Commissioning-Policy-No-4-Application-Amendment-Waiver-of-Policies-for-the-Comm-of-Appropriate-Effective-and-Priority-Health-Care 0.4 MB2
Fwccg-Commissioning-Policy-No-4-att-Process-map-appeals-v3 0.1 MB2
Fwccg-Commissioning-Policy-No-9-Reversal-of-Sterilisation 0.1 MB5
Fwccg-Complementary-and-Alternative-Therapies-new-Jan-2018 88 KB4
Fwccg-Policy For Commissioning Spinal Injection Radiofrequency Denervation For Low Back Pain V1 0.6 MB5
Fwccg-Policy Number 1 Statement Of Principles 0.3 MB2
Fwccg-Policy Number 2 General Policy IFR Decision Making 0.4 MB7
Fwccg-Policy Number 3 Considering Applications For Exceptionality 0.3 MB8
Fwccg-Policy-for-Assisted-Conception-Services 0.3 MB19
Fwccg-Policy-for-cosmetic-procedures-0318 64 KB12
Fwccg-Policy-for-Endoscopic-Procedures-on-the-Knee-Joint-Cavity-July-2017-v6 . 0.2 MB3
Fwccg-Policy-for-excision-of-the-uterus-v1 0.1 MB7
Fwccg-Policy-for-Grommets-v1 0.1 MB6
Fwccg-Policy-for-Hip-Arthroscopy-0318 42 KB5
Fwccg-Policy-for-hysteroscopy-0318 44 KB5
Fwccg-Policy-for-insulin-pump-provision-v1 0.1 MB2
Fwccg-Policy-for-Male-Circumcision-v4 0.2 MB3
Fwccg-Policy-for-photorefractive-surgery-v1 0.1 MB3
Fwccg-Policy-for-Surgical-Release-of-Trigger-Finger-Vs5-141216 0.2 MB6
Fwccg-Policy-for-Surgical-Treatment-of-Carpal-Tunnel-Syndrome-V5-050717 0.2 MB5
Fwccg-Policy-for-the-provision-of-Glucose-Monitoring-Devices-v1 0.2 MB4
Fwccg-Policy-for-Tonsillectomy-Adeno-Tonsillectomy-V8-050717 0.2 MB8
Fwccg-Policyfor-Dilatation-and-Curettage-0318 45 KB3

Commissioning Policy summaries

Corporate Policies

Information Governance

Medicines Optimisation

NameSizeHits
Actipatch for pain management 0.6 MB12
Albiglutide for type-2 diabetes mellitus 0.3 MB8
Alprostadil Cream For ED 0.3 MB6
Azelastine Fluticasone (Dymista) Nasal Spray 0.1 MB7
Bazedoxifene for oestrogen deficiency symptoms 0.3 MB7
Botulinum Toxin A for Spasticity and Contracture of the joint 0.3 MB6
Brimonidine For Erythema Of Rosacea 0.1 MB7
Brivaracetam for epilepsy 0.3 MB7
Budesonide multimatrix MMX 9mg prolonged release tablets 0.2 MB8
Certolizumab For Psoriatic Arthritis 0.1 MB8
Co-Proxamol For pain management 0.3 MB5
Co-trimoxazole for the prophylaxis of pneumocystis jirovecii (pneumocystis carinii) infections 0.3 MB5
Co-trimoxazole Prophylaxis of Primary and Secondary Spontaneous Bacterial Peritonitis (SBP) 0.1 MB6
Colesevelam (Cholestagel® ) For combination or monotherapy for familial hypercholesterolaemia 0.3 MB2
Colistimethate sodium/Colistin sulfomethate sodium (Colomycin® ) For non-Cystic Fibrosis in Patients with Bronchiectasis Colonised with Pseudomonas Aeruginosa 0.2 MB2
Conditions for which over the counter items should not routinely be prescribed in primary care 0.9 MB8
Daily selective serotonin re-uptake inhibitors (SSRIs) for the treatment of premature ejaculation (PE) 0.2 MB2
Dapoxetine for the treatment of premature ejaculation (PE) 0.2 MB3
Dulaglutide for the treatment of Type II Diabetes Mellitus in adults 0.3 MB5
Eflornithine-cream-for-facial-hirsutism 0.2 MB3
Eltrombopag For Thrombocytopenia In Hepatitis C 0.1 MB2
Eslicarbazepine For Focal Seizures 0.1 MB4
Evolocumab (Repatha SureClick® ) For prevention of cardiac events in patients with CHD and a history of ACS, in combination with a statin 0.1 MB2
Ferric Maltol 30mg Capsules in Adults for the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease 0.3 MB3
Fluorouracil-5-cream-for-basal-cell-carcinomas 0.1 MB2
Gluten-Free-Food-Products 0.3 MB5
Guanfacine-for-ADHD 0.3 MB4
Imiquimod-5-cream-for-basal-cell-carcinomas 0.2 MB2
Insulin Degludec And Liraglutide 0.2 MB3
Insulin-Aspart-for-Diabetes-Mellitus 0.3 MB3
Insulin-Degludec-for-DM 0.3 MB4
Insulin-Detemir-for-DM 0.2 MB2
Insuline-Glargine-for-T1DM 0.3 MB2
Insuline-Glargine-for-T2DM 0.3 MB2
Invicorp-injection-for-erectile-dysfunction 0.3 MB5
Ivermectin-cream-for-rosacea 0.3 MB2
JIA Policy For Adults (Version 1.0) 0.2 MB3
Lamotrigine-for-trigeminal-neuralgia 0.3 MB3
Lamotrigine-for-trigeminal-neuralgia 2 0.3 MB4
Levonorgestrel 13.5mg IUD 0.3 MB2
Lidocaine Plasters For PHN 0.2 MB2
Lidocaine-plasters-for-unlicensed-indications 0.3 MB4
Liothyronine-for-refractory-hypothyroidism 0.2 MB6
Liraglutide-for-obesity 0.3 MB2
Lisdexamfetamine-for-ADHD-in-adults 0.3 MB3
Lisdexamfetamine-for-ADHD-update 0.3 MB4
Lurasidone-for-Schizophrenia 0.3 MB3
Magnaspartate For Hypomagnesaemia 0.3 MB2
Metformin-for-reductionof-risk-or-delay-type-2-daibetes 0.2 MB3
Metformin-for-reductionof-risk-or-delay-type-2-daibetes 2 0.2 MB3
Midazolam-Epistatus-for-seizures 0.2 MB3
Opicapone-for-Parkinsons-disease-v2 0.5 MB5
Oxycodone-Naloxone-for-Restless-legs 0.3 MB2
Paravit-CF-for-dietary-management-of-patients-with-cystic-fibrosis 0.2 MB10
Patiromer-for-hyperkalaemia 0.3 MB2
Patiromer-for-hyperkalaemia 2 0.3 MB3
Phosphodiesterase Type-5 Inhibitors 0.2 MB2
Pitolisant-for-Narcolepsyv2 0.3 MB3
Policy On Brand Inhaler Prescribing 0.3 MB4
Probiotics And VSL 0.3 MB5
Relvar Ellipta For COPD And Asthma 0.2 MB5
Rituximab-for-AIHA 0.4 MB6
Rituximab-for-ITP 0.4 MB4
Rivaroxaban-10mg-for-DVT-and-PE-and-extended-use 0.1 MB6
Safinamide-for-Parkinsons-disease 0.3 MB2
Second Line Anti-TNF For PsA 0.2 MB2
Second-generation-LA-antipsychotics 0.3 MB4
Secukinumab-for-Palmoplantar-psoriasis 0.3 MB2
Secukinumab-for-Palmoplantar-psoriasis 2 0.3 MB4
Silk Garments For Eczema And Dermatitis 0.2 MB3
Simbrinza for chronic open angle glaucoma 0.1 MB3
Sodium Oxybate for Narcolepsy with Cataplexy 0.3 MB3
Spironolactone For Acne 0.1 MB2
Subcutaneous Depot Medroxyprogesterone Acetate 0.1 MB2
Tadalafil daily 0.3 MB4
Tapentadol for neuropathic pain in non-palliative care 0.4 MB5
Tapentadol for non-specific pain 0.2 MB3
Testosterone For Female Sexual Dysfunction 0.1 MB2
Tiotropium For Asthma 0.2 MB2
Tocilizumab SC For RA 0.1 MB3
Trelegy inhaler for COPD 0.3 MB5
Trimbow inhaler for COPD 0.4 MB3
Trimbow-inhaler-for-COPD 0.4 MB4
Ulipristal acetate for uterine fibroids 0.5 MB6
Umeclidinium For COPD 0.2 MB4
Vedolizumab For Crohn's Disease 0.2 MB2
Vesomni For Benign Prostatic Hyperplasia 0.1 MB2
Vitamins (inc Renavit) For Dialysis 0.3 MB3
Waterproof Cast Cover Policy 0.1 MB3

Last updated on 8 February 2019 at 13:53 by communications manager